Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
Daiichi Sankyo Acquires Amcor Facility

February 16, 2011
Daiichi Sankyo, Inc. (DSI) has acquired a 140,000 sq.-ft. facility in Bethlehem, PA from Amcor, in a transaction valued at $10.3 million.  Read More »
NSF Acquires Pharmalytica Services

February 16, 2011
NSF International has acquired Pharmalytica Services, a pharmaceutical contract lab based in Connecticut.  Read More »
Creapharm, BioConvergence Bridge Services

February 16, 2011
BioConvergence and Creapharm have partnered in an effort to provide customers with lower costs, reduced risks, and increased control of projects.   Read More »
BASi Expands Discovery Services

February 16, 2011
BASi (Bioanalytical Systems, Inc.) has added the ability to work with large animals through its Culex Automated In Vivo Discovery Services.  Read More »
Ricerca Sells Bothell Site to Numira

February 15, 2011
Ricerca Biosciences has sold its Bothell (West), WA in vivo operation to Numira Biosciences, a CRO specializing in high-resolution imaging and analysis of small animal specimens.  Read More »
Takeda, Covance and Quintiles Enter Strategic Pact

February 15, 2011
Takeda’s Pharmaceutical Development Division has entered into strategic partnerships with Covance and Quintiles to plan and execute global development programs to support new compounds in all therapeutic areas, except oncology.  Read More »
Catalent Acquires Lyopan Technology

February 15, 2011
Catalent Pharma Solutions has entered into a license agreement with Pantec AG for the exclusive worldwide development rights to the Lyopan fast-dissolve technology for healthcare products.  Read More »
Kendle

February 15, 2011
Candace Kendle, Pharm.D., will step down from her role as Kendle’s chief executive officer, effective May 1.  Read More »
Lilly’s Mirror Portfolio Marks Milestone

February 15, 2011
A venture capital firm involved in Lilly’s Mirror Portfolio, a concept created by Lilly to access innovation developed outside the company, has acquired two molecules and will oversee further development.  Read More »
Lucentis Meets Phase III Endpoint in DME

February 14, 2011
Genentech’s Phase III study evaluating monthly Lucentis (ranibizumab injection) in patients with diabetic macular edema (DME), met its primary endpoint.  Read More »
BrainStorm’s NurOwn Gets Orphan Status

February 14, 2011
BrainStorm Cell Therapeutics, Inc. has been granted orphan drug designation for its NurOwn autologous adult stem cell candidate for the treatment of amyotrophic lateral sclerosis (ALS), referred to as Lou Gehrig's Disease.   Read More »
BioSante’s LibiGel Shows Positive Safety Profile

February 14, 2011
BioSante Pharmaceuticals, Inc. achieved positive safety data in its Phase III program for LibiGel (testosterone gel) in development for the treatment of female sexual dysfunction (FSD) and hypoactive sexual desire disorder (HSDD) in menopausal women.  Read More »
Tarsa Completes Phase III Oral Calcitonin Trial

February 14, 2011
Tarsa Therapeutics, Inc. has completed its global Phase III ORACAL trial with once-daily oral recombinant calcitonin for the treatment of postmenopausal osteoporosis.  Read More »
DPT Laboratories

February 11, 2011
Grant Gilker has been named general manager of operations at DPT’s Center of Excellence for semi-solids and liquids manufacturing facility in San Antonio, TX.  Read More »
Crucell Resolves Issues at South Korea Plant

February 11, 2011
Crucell NV can resume selling its vaccine Quinvaxem to United Nations agencies, after investigations by the World Health Organization showed the manufacturing problems at Crucell’s plant in South Korea were resolved.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: